Wilmington plc (LON:WIL)

Sage Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	311	348	244	201	185	108
Market Cap Growth	17.88%	42.61%	21.33%	8.50%	71.78%	-37.41%
Enterprise Value	282	330	231	200	220	161
Last Close Price	3.48	3.79	2.62	2.11	1.89	1.09
PE Ratio	22.78	8.44	12.08	6.13	-	23.08
Forward PE	15.22	17.26	13.12	12.20	15.67	9.77
PS Ratio	3.08	3.54	2.62	1.66	1.64	0.95
PB Ratio	2.77	3.02	3.03	3.00	5.05	2.49
P/TBV Ratio	20.15	6.65	17.00	-	-	-
P/FCF Ratio	17.79	15.53	8.29	10.10	15.42	5.49
P/OCF Ratio	17.73	15.44	8.16	9.88	14.18	5.34
PEG Ratio	6.03	0.93	0.93	0.93	0.93	0.93
EV/Sales Ratio	2.79	3.36	2.48	1.65	1.95	1.43
EV/EBITDA Ratio	11.69	14.47	10.75	8.52	12.34	10.65
EV/EBIT Ratio	14.02	16.84	12.68	9.94	16.60	17.46
EV/FCF Ratio	16.14	14.73	7.83	10.03	18.29	8.20
Debt / Equity Ratio	0.02	0.03	0.09	0.10	0.95	1.42
Debt / EBITDA Ratio	0.09	0.12	0.31	0.28	1.74	3.58
Debt / FCF Ratio	0.12	0.13	0.25	0.35	2.90	3.14
Asset Turnover	0.64	0.62	0.68	0.93	0.76	0.72
Quick Ratio	1.06	1.61	1.16	0.86	0.53	0.71
Current Ratio	1.08	1.70	1.23	0.95	0.62	0.79
Return on Equity (ROE)	14.26%	17.55%	23.25%	63.27%	-11.36%	10.84%
Return on Assets (ROA)	7.90%	7.72%	8.26%	9.66%	5.59%	3.69%
Return on Capital (ROIC)	12.35%	11.89%	14.06%	17.27%	9.38%	6.08%
Return on Capital Employed (ROCE)	17.10%	16.60%	20.60%	26.00%	19.20%	8.80%
Earnings Yield	11.81%	11.84%	8.28%	16.32%	-2.45%	4.33%
FCF Yield	5.62%	6.44%	12.07%	9.90%	6.49%	18.22%
Dividend Yield	3.25%	2.98%	3.82%	3.89%	3.17%	-
Payout Ratio	27.69%	22.21%	36.95%	16.73%	-	93.67%
Buyback Yield / Dilution	-0.72%	-0.49%	-1.67%	-1.32%	1.40%	-0.69%
Total Shareholder Return	2.60%	2.49%	2.15%	2.57%	4.57%	-0.69%

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.